Avalyn Pharma Inc. Common Stock ( AVLN) - Stock Earnings
AVLN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -20.2 million USD | — USD |
| 2026Q1 | -26.9 million USD | — USD |
| 2026Q2 | -28.9 million USD | — USD |
| 2026Q4 Est. | — | — |
AVLN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -49.7 million USD | — USD |
| 2025 | -85.2 million USD | — USD |
| 2026 Est. | — | — |
AVLN
Price: $26.29
52 week price:
Earnings Per Share: -2.33 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 1.2 billion